Ceftibuten
Ceftibuten is a pharmaceutical drug with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants
Clinical Trials (8)
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants
To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults
PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment
Short-term Antibiotic Therapy for Pyelonephritis in Childhood
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8